Opinion

Video

Exploring LBCL: Transplant Eligibility and Second Line Treatment Selection of Novel Agents

Fred Locke, MD, provides an overview of transplant eligibility for patients with large B-cell lymphoma, highlighting second line strategies with CAR T-cell therapy and bispecific antibodies.

Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Francine Foss, MD
David C. Fisher, MD